APA (7th ed.) Citation

M, Z., L, N., H, L., Z, L., H, Z., Z, L., . . . M, Y. (2026). Addition of angiogenesis inhibitors to CDK4/6 inhibitors and fulvestrant in hormone receptor-positive, HER2-negative advanced breast cancer. Chinese medical journal. https://doi.org/10.1097/CM9.0000000000004191

Chicago Style (17th ed.) Citation

M, Zhang, et al. "Addition of Angiogenesis Inhibitors to CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer." Chinese Medical Journal 2026. https://doi.org/10.1097/CM9.0000000000004191.

MLA (9th ed.) Citation

M, Zhang, et al. "Addition of Angiogenesis Inhibitors to CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer." Chinese Medical Journal, 2026, https://doi.org/10.1097/CM9.0000000000004191.